Market Overview

Agrium Downgraded To Sell, But CLSA Raises Price Target

Related AGU
Wall Street's M&A Chatter From December 12: Fox-Disney, Repros Therapeutics-Allergan, Agrium-Macrofertil
Earnings Scheduled For November 7, 2017

Despite a recovering ag cycle, CLSA gets even more bearish on Agrium Inc. (USA) (NYSE: AGU). Earlier Thursday, CLSA released a note saying Agrium would need retail to have a dramatic uptick to keep up with its aspirations.

One of the reasons for the downgrade is that there aren't any levers to pull. After nitrogen plants have stabilized, and getting Vanscoy working, there aren't many ways to keep up with its new targets.

One piece of good news is that Agrium's assets are functioning well and urea prices will move up soon, helping margins. However, Agrium has yet to revise its guidance to incorporate a wide potential of outcomes.

Although CLSA downgraded Agrium to Sell, shares are up 3.71 percent on the day at $12.86. The estimates in the note didn't change for Agrium's earnings, but CLSA adjusts price target upwards from $84 to $86.

Latest Ratings for AGU

Dec 2017Stephens & Co.Initiates Coverage OnOverweight
Oct 2017HSBCInitiates Coverage OnBuy
Sep 2017TD SecuritiesUpgradesHoldBuy

View More Analyst Ratings for AGU
View the Latest Analyst Ratings

Posted-In: CLSAAnalyst Color Downgrades Price Target Analyst Ratings


Related Articles (AGU)

View Comments and Join the Discussion!